Clinical Trials in Spain

• A Phase 2 study (NEPTUNE-17) to evaluate efficacy and safety of GSK3858279 in DPNP. Ended
  2022-502313-28-00 Phase II Diabetic Peripheral Neuropathic Pain Glaxosmithkline Research & Development Limited
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the … Ended
  2023-503614-80-00 Phase III Pulmonary Arterial Hypertension GB002 Inc.
• Extension Study to Assess Batoclimab in Participants with TED. Ended
  2024-512650-21-00 Phase III Thyroid Eye Disease (TED) Immunovant Sciences GmbH
• A study to learn if atrasentan is safe and works in people with IgA nephropathy who are taking an SGLT2i Ended
  2023-503828-13-00 Phase II Nephrology Novartis Pharma AG
• A Randomized, Double-Blind, Placebo-Controlled, Parallel, 4-Arm Dose Ranging Study of the Safety and Efficacy of Nalbuphine Extended-Release… Ended
  2023-505296-72-00 Phase II Idiopathic Pulmonary Fibrosis (IPF) Trevi Therapeutics Inc.
• A randomized controlled trial comparing sequential of two shots of CFA vs CFA + rFSH for Elective Fertility Preservation. The 2-shot protoco… Ended
  2023-506162-31-00 Phase III Infertility Santiago Dexeus Font Fundacio Privada
• A trial to examine the biological effects of Saruparib (AZD5305) alone, Darolutamide alone, and in combination in patients with newly diagno… Ended
  2023-503691-25-00 Phase I (Other) Newly diagnosed prostate cancer AstraZeneca AB
• A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate the efficacy and safety of vilobelimab … Ended
  2023-506250-20-00 Phase III ulcerative pyoderma gangrenosum InflaRx GmbH
• Study of ART0380 in Advanced/Metastatic Solid Tumors Patients (ARTIST) Ended
  2023-504153-12-00 Phase II Advanced or Metastatic Solid Tumors Artios Pharma Limited
• A study to evaluate the efficacy, safety, participant choice and preference of an oral once-daily regimen or a long-acting injectable regim… Ended
  2023-503893-19-00 Phase III HIV-1 infection Viiv Healthcare UK Limited
• Efficacy and Safety of JNJ-77242113 in Participants with Moderately to Severely Active Ulcerative Colitis Ended
  2023-504673-20-00 Phase II Ulcerative Colitis Janssen - Cilag International
• A study on the reactogenicity, safety, immune response, and efficacy of a targeted immunotherapy against HSV in healthy participants aged 18… Ended
  2024-510571-37-00 Phase I (FiH) Herpes Simplex GlaxoSmithKline Biologicals
• BRIGHT - A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug… Ended
  2022-502001-15-00 Phase II Acute Ischemic Stroke (AIS) Lumosa Therapeutics Co. Ltd.
• A Study to Evaluate Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants with Relapsed or … Ended
  2023-503689-21-00 Phase I/II Multiple myeloma (MM) F. Hoffmann-La Roche AG
• Clinical and endocrinological effects of letrozole during the luteal phase after controlled ovarian stimulation in oocyte donors: a low inte… Ended
  2022-502586-21-00 Phase III Female Infertility Ivi Madrid S.L.
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First in-Human, Consecutive-Cohort, Clinical Trial of BI 1910, a Monoclonal Antibody to… Ended
  2022-503066-74-00 Phase I (FiH) Advanced solid tumors Bioinvent International AB
• This is a clinical trial (study), to be conducted in several clinical sites worldwide, of an oral study drug which will be investigated in a… Ended
  2023-503957-36-00 Phase II/III Moderate-to-Severe pruritus in adult subjects with notalgia … Cara Therapeutics Inc.
• Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alz… Ended
  2022-503148-41-00 Phase II Alzheimer's disease Prinnovation GmbH
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination with a Checkpoint Inhibitor with or without Stand… Ended
  2022-502615-11-00 Phase I Locally Advanced or Metastatic Solid Tumors Genentech Inc.
• A Ph2 dose-finding study (MARS-17) to evaluate the efficacy and safety of GSK3858279 in adults with knee osteoarthritis pain. Ended
  2022-502799-22-00 Phase II Knee osteoarthritis pain Glaxosmithkline Research & Development Limited
• Ph 3b, BIC/FTC/TAF to DTG/3TC FDC, 96 Week switch, efficacy, safety, and tolerability study in ART-experienced older adults living with HIV … Ended
  2022-503137-66-00 Phase III Human immunodeficiency virus (HIV) Viiv Healthcare UK Limited
• BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidne… Ended
  2023-503336-41-00 Phase II Prophylaxis of Renal Allograft Rejection Eledon Pharmaceuticals Inc.
• A Study Evaluating the Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients with Surgically Resectable Hepatocellular C… Ended
  2022-502840-11-00 Phase I/II Hepatocellular Carcinoma (Morpheus-Neo HCC) F. Hoffmann-La Roche AG
• A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized… Ended
  2023-504487-41-00 Phase III COVID-19 University Of Minnesota

Showing 3,889–3,912 of 4,859 trials